SF3B1 and B-cell chronic lymphocytic leukemia: Murine models with conditional heterozygous expression of splicing factor (SF) mutations (SF3B1, U2AF1, SRSF2, ZRSR2) have confirmed the causative effects of RNA splicing dysregulation in the pathogenesis of myeloid malignancies and CLL (5, 30, 42–45).